Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ACADACAD
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ACADIA PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 2.6M shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $65.3M as of 2026-Q2. The position was increased (+65.6% shares). ACAD represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$65.3M

Current Shares

2.6M

Total Value Change

+$65.3M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+65.6%
$65.3M0.0%$25.30
43
2026-Q1
Decreased
1.6M
-0.8%
$34.7M0.0%$22.26
0
2025-Q4
Decreased
1.6M
-25.3%
$41.9M0.0%$26.71
0
2025-Q3
Increased
2.1M
+43.2%
$44.9M0.0%$21.34
39
2025-Q2
Decreased
1.5M
-32.6%
$31.7M0.0%$21.57
0
2025-Q1
Decreased
2.2M
-24.4%
$36.2M0.0%$16.61
0
2024-Q4
Increased
2.9M
+63.8%
$52.9M0.0%$18.35
43
2024-Q3
Increased
1.8M
+31.2%
$27.1M0.0%$15.38
36
2024-Q2
Increased
1.3M
+84.2%
$21.8M0.0%$16.25
44
2024-Q1
Decreased
727,905
-9.5%
$13.5M0.0%$18.49
0
2023-Q4
Increased
804,170
+11.9%
$25.2M0.0%$31.31
32
2023-Q3
Decreased
718,625
-43.6%
$15M0.0%$20.84
0
2023-Q2
Increased
1.3M
+30.0%
$30.5M0.0%$23.95
36
2023-Q1
Decreased
979,738
-1.1%
$18.4M0.0%$18.82
0
2022-Q4
Decreased
990,623
-16.1%
$15.8M0.0%$15.92
0
2022-Q3
Increased
1.2M
+11.6%
$19,3110.0%$16.36
21
2022-Q2
First report
1.1M
-
$14,9000.0%$14.09
0

Other major holders of ACAD: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used